Status:
COMPLETED
Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
Lead Sponsor:
AstraZeneca
Conditions:
Reflux
Heartburn
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this project is to compare the GERD clinical outcomes in patients where a structured pathway using the GerdQ questionnaire is implemented compared with the clinical outcomes of those treate...
Detailed Description
In Norway, it is developed as a clinical trial where a new structured pathway in the diagnosis and treatment of GERD is compared to the ordinary clinical pathway consisting of the endoscopic/pH-metry ...
Eligibility Criteria
Inclusion
- Patients presenting with symptoms suggestive of GERD (heartburn or regurgitation as prevailing symptoms) of any severity
- Patient able to understand and complete the questionnaires
Exclusion
- Alarm symptoms (Dysphagia/odynophagia, anorexia, anaemia, unintentional weight loss, abdominal mass, upper GI bleeding)
- If the patient is participating in any clinical trial, he/she cannot take part on this study
- Any condition that, in the investigator's opinion, makes the patient's participation in the study difficult
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
2370 Patients enrolled
Trial Details
Trial ID
NCT00842387
Start Date
January 1 2009
End Date
December 1 2009
Last Update
December 23 2009
Active Locations (66)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Amstetten, Austria
2
Research Site
Baden, Austria
3
Research Site
Bludenz, Austria
4
Research Site
Bregenz, Austria